| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Feb―03 |
Response to letter to the editor “Hypopituitarism and COVID-19, what else?” |
Giulia Carosi, Giovanna Mantovani, Luigi Di Filippo, Andrea Giustina |
| 2 |
[GO] |
2024―Dez―21 |
Hypopituitarism and COVID-19, what else? |
Luis Del Carpio-Orantes |
| 3 |
[GO] |
2024―Nov―19 |
Hypopituitarism and COVID-19 |
Giulia Carosi, Arianna Cremaschi, Claudia Giavoli, Emanuele Ferrante, Giovanna Mantovani |
| 4 |
[GO] |
2024―Nov―14 |
Cushing’s syndrome and COVID-19 |
Amina Attia, Jérôme Bertherat |
| 5 |
[GO] |
2024―Okt―15 |
Hypophysitis in COVID-19: a systematic review |
Sara Menotti, Luigi di Filippo, Umberto Terenzi, Sabrina Chiloiro, Laura De Marinis |
| 6 |
[GO] |
2024―Sep―09 |
SARS-CoV-2 infection and vaccination in patients with pituitary diseases: the experience of a Brazilian reference center |
Marcela Cunha da Silva, Solena Ziemer Kusma Fidalski, Cesar Luiz Boguszewski |
| 7 |
[GO] |
2024―Sep―06 |
Long COVID and pituitary dysfunctions: a bidirectional relationship? |
Luigi di Filippo, Vincenzo Franzese, Simona Santoro, Mauro Doga, Andrea Giustina |
| 8 |
[GO] |
2024―Aug―28 |
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19 |
Alessandro Peri, Laura Naldi, Dario Norello, Benedetta Fibbi |
| 9 |
[GO] |
2024―Aug―05 |
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era |
Andre E. Boyke, Michelot Michel, Adam N. Mamelak |
| 10 |
[GO] |
2024―Jul―26 |
Precocious puberty, pandemic and beyond |
Guillermo F. Alonso |
| 11 |
[GO] |
2024―Jul―24 |
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence |
Anthony Tang, Hussein M. Abdallah, Yue-Fang Chang, Georgios A. Zenonos, Paul A. Gardner, Garret W. Choby, et al. (+2) Eric W. Wang, Carl H. Snyderman |
| 12 |
[GO] |
2024―Mai―31 |
Acromegaly and COVID-19, lessons, and new opportunities |
Elena V. Varlamov, Maria Fleseriu |
| 13 |
[GO] |
2024―Mai―18 |
Pituitary and COVID-19 vaccination: a systematic review |
Martina Verrienti, Valentino Marino Picciola, Maria Rosaria Ambrosio, Maria Chiara Zatelli |
| 14 |
[GO] |
2023―Nov―17 |
Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency |
David S. McLaren, Grace Crowe, Christine Cassidy, Irum Rasool, Mohammed Elsabbagh, Ahmad Eyadeh, et al. (+11) Nang P. P. H. Htwe, Melinda Gerrard, Emma Ward, Saifuddin Kassim, Afroze Abbas, Ahmed Al-Qaissi, Khyatisha Seejore, Nikolaos Kyriakakis, Deirdre Maguire, Julie Lynch, Robert D. Murray |
| 15 |
[GO] |
2021―Mai―03 |
COVID-19 and the pituitary |
Stefano Frara, Agnese Allora, Laura Castellino, Luigi di Filippo, Paola Loli, Andrea Giustina |
| 16 |
[GO] |
2021―Mrz―05 |
Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease |
Emre Durcan, Senol Turan, Serdar Sahin, Cem Sulu, Sabriye Sibel Taze, Yasin Kavla, et al. (+2) Hande Mefkure Ozkaya, Pinar Kadioglu |
| 17 |
[GO] |
2021―Feb―10 |
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement |
Laurence Katznelson, Mônica Gadelha |
| 18 |
[GO] |
2020―Nov―24 |
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study |
Anneke Graf, Hani J. Marcus, Stephanie E. Baldeweg |
| 19 |
[GO] |
2020―Sep―11 |
Pituitary apoplexy associated with acute COVID-19 infection and pregnancy |
Julie L. Chan, Kimberly D. Gregory, Sarah S. Smithson, Mariam Naqvi, Adam N. Mamelak |
| 20 |
[GO] |
2020―Jun―18 |
Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective |
Maria Fleseriu, Michael Buchfelder, Justin S. Cetas, Pouneh K. Fazeli, Susana M. Mallea-Gil, Mark Gurnell, et al. (+5) Ann McCormack, Maria M. Pineyro, Luis V. Syro, Nicholas A. Tritos, Hani J. Marcus |
